{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:07:46Z","timestamp":1785928066492,"version":"3.56.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006054","name":"Universidad de Guanajuato","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bioorg.2025.109245","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:42:46Z","timestamp":1763646166000},"page":"109245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development of benztropine-based DAT blockers for Parkinson's disease interventions: A biologic and synthetic overview"],"prefix":"10.1016","volume":"168","author":[{"given":"Edson D.","family":"Hern\u00e1ndez-Vel\u00e1zquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Ch\u00e1vez-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Ort\u00edz-Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar R.","family":"Solorio-Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"33","key":"10.1016\/j.bioorg.2025.109245_bb0005","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1002\/anie.200902248","article-title":"Evolution of Propargyl ethers into Allylgold cations in the cyclization of Enynes","volume":"48","author":"Jim\u00e9nez-N\u00fa\u00f1ez","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"issue":"34","key":"10.1016\/j.bioorg.2025.109245_bb0010","doi-asserted-by":"crossref","first-page":"11881","DOI":"10.1021\/ja104743k","article-title":"Gold-catalyzed annulation\/fragmentation: formation of free gold Carbenes by retro-Cyclopropanation","volume":"132","author":"Solorio-Alvarado","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"31","key":"10.1016\/j.bioorg.2025.109245_bb0015","doi-asserted-by":"crossref","first-page":"11952","DOI":"10.1021\/ja205046h","article-title":"Cyclopropanation with gold(I) Carbenes by retro-Buchner reaction from Cycloheptatrienes","volume":"133","author":"Solorio-Alvarado","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"52","key":"10.1016\/j.bioorg.2025.109245_bb0020","doi-asserted-by":"crossref","first-page":"13093","DOI":"10.1002\/anie.201207682","article-title":"Gold for the generation and control of fluxional Barbaralyl cations","volume":"51","author":"McGonigal","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"issue":"40","key":"10.1016\/j.bioorg.2025.109245_bb0025","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1039\/C8OB02056F","article-title":"Gold(i)-catalysed high-yielding synthesis of indenes by direct Csp3\u2013H bond activation","volume":"16","author":"Nahide","year":"2018","journal-title":"Org. Biomol. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109245_bb0030","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.1021\/acsomega.1c06637","article-title":"Gold(I)-catalyzed synthesis of 4H-benzo[d][1,3]oxazines and biological evaluation of activity in breast Cancer cells","volume":"7","author":"Segura-Quezada","year":"2022","journal-title":"ACS Omega"},{"issue":"23","key":"10.1016\/j.bioorg.2025.109245_bb0035","doi-asserted-by":"crossref","first-page":"17069","DOI":"10.1021\/acs.joc.4c01309","article-title":"Gold(I)-catalyzed synthesis of 2,2\u2032-biindoles Via One-Pot double cycloisomerization strategy","volume":"89","author":"Ibarra-Guti\u00e9rrez","year":"2024","journal-title":"J. Org. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109245_bb0040","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tetlet.2016.11.093","article-title":"Mild, rapid and efficient metal-free synthesis of 2-aryl-4-aryloxyquinolines via direct Csp2O bond formation by using diaryliodonium salts","volume":"58","author":"Nahide","year":"2017","journal-title":"Tetrahedron Lett."},{"issue":"33","key":"10.1016\/j.bioorg.2025.109245_bb0045","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1002\/anie.201304359","article-title":"Site-selective oxidation of Unactivated CH bonds with Hypervalent iodine (III) reagents","volume":"52","author":"Moteki","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109245_bb0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.15174\/au.2017.1337","article-title":"Oxidaci\u00f3n sin Precedente y Escalable Catalizada por Cobre (I) del Enlace Csp2-H en el 2-Fenil-1,3-Naftalendiol con Ox\u00edgeno Atmosf\u00e9rico: S\u00edntesis de la 2-Hidroxi-3-fenil-1,4-Naftoquinona via Formaci\u00f3n Directa del Enlace Csp2-O","volume":"27","author":"Guardado-Cruz","year":"2017","journal-title":"Acta Universitaria"},{"issue":"32","key":"10.1016\/j.bioorg.2025.109245_bb0055","doi-asserted-by":"crossref","first-page":"17806","DOI":"10.1039\/C8RA02982B","article-title":"Practical, mild and efficient electrophilic bromination of phenols by a new I(iii)-based reagent: the PIDA\u2013AlBr3 system","volume":"8","author":"Satkar","year":"2018","journal-title":"RSC Adv."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109245_bb0060","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1021\/acs.orglett.8b04141","article-title":"Iodine(III)-catalyzed electrophilic nitration of phenols via non-Br\u00f8nsted acidic NO2+ generation","volume":"21","author":"Ju\u00e1rez-Ornelas","year":"2019","journal-title":"Org. Lett."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109245_bb0065","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1021\/acs.joc.9b00161","article-title":"Iodine(III)-mediated, controlled Di- or Monoiodination of phenols","volume":"84","author":"Satkar","year":"2019","journal-title":"J. Organomet. Chem."},{"issue":"23","key":"10.1016\/j.bioorg.2025.109245_bb0070","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.tetlet.2019.05.019","article-title":"Iodine(III)\/AlX3-mediated electrophilic chlorination and bromination of arenes. Dual role of AlX3 (X\u00a0=\u00a0cl, Br) for (PhIO)n depolymerization and as the halogen source","volume":"60","author":"Segura-Quezada","year":"2019","journal-title":"Tetrahedron Lett."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109245_bb0075","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/00397911.2019.1707225","article-title":"Iodine(III)-catalyzed benzylic oxidation by using the (PhIO)n\/Al(NO3)3 system","volume":"50","author":"Yahuaca-Ju\u00e1rez","year":"2020","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2025.109245_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.563470","article-title":"The Diaryliodonium(III) salts reaction with free-radicals enables one-pot double Arylation of Naphthols","volume":"8","author":"Satkar","year":"2020","journal-title":"Front. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109245_bb0085","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/1570193X17999200504095803","article-title":"Oxidative halogenation of Arenes, olefins and alkynes mediated by iodine(III) reagents","volume":"18","author":"Segura-Quezada","year":"2021","journal-title":"Mini-Rev. Org. Chem."},{"issue":"25","key":"10.1016\/j.bioorg.2025.109245_bb0090","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1039\/D2OB00741J","article-title":"Iodine(iii) reagents for oxidative aromatic halogenation","volume":"20","author":"Segura-Quezada","year":"2022","journal-title":"Org. Biomol. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109245_bb0095","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1039\/D1OB02501E","article-title":"Diaryliodonium(iii) salts in one-pot double functionalization of C\u2013IIII and ortho C\u2013H bonds","volume":"20","author":"Kikushima","year":"2022","journal-title":"Org. Biomol. Chem."},{"issue":"37","key":"10.1016\/j.bioorg.2025.109245_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202201897","article-title":"Indomethacin synthesis, historical overview of their structural modifications","volume":"7","author":"Torres-Carbajal","year":"2022","journal-title":"ChemistrySelect"},{"issue":"21","key":"10.1016\/j.bioorg.2025.109245_bb0105","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.2174\/1385272826666220621142211","article-title":"Iodine(III)-mediate oxidative Cyanation, Azidation, nitration, Sulfenylation and Slenization in olefins and aromatic systems","volume":"26","author":"Luis","year":"2022","journal-title":"Curr. Org. Chem."},{"issue":"47","key":"10.1016\/j.bioorg.2025.109245_bb0110","article-title":"Iodine(III)-mediated electrophilic chlorination and catalytic nitration of N-Tosyl anilines","volume":"2022","author":"Patil","year":"2022","journal-title":"Eu. J. Org. Chem."},{"issue":"45","key":"10.1016\/j.bioorg.2025.109245_bb0115","article-title":"Iodine(III)-mediated free-aniline iodination through acetyl Hypoiodite formation: study of the reaction pathway","volume":"2022","author":"Mali","year":"2022","journal-title":"Eu. J. Org. Chem."},{"issue":"47","key":"10.1016\/j.bioorg.2025.109245_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202303425","article-title":"Iodine(III)-aluminum or -ammonium salts for the oxidative aromatic inorganic functionalization","volume":"8","author":"Ch\u00e1vez-Rivera","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.109245_bb0125","first-page":"1580","article-title":"Divergent role of PIDA and PIFA in the AlX3 (X = cl, Br) halogenation of 2-naphthol: a mechanistic study","volume":"20","author":"Ju\u00e1rez-Ornelas","year":"2024","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.109245_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2024.134203","article-title":"Iodine(III) reagents for the aromatic functionalization with inorganic groups","volume":"166","author":"Barrera-Nava","year":"2024","journal-title":"Tetrahedron"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109245_bb0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3998\/ark.5550190.p009.631","article-title":"A four-step scalable formal synthesis of ningalin C","volume":"2016","author":"Ramadoss","year":"2016","journal-title":"ARKIVOC"},{"issue":"17","key":"10.1016\/j.bioorg.2025.109245_bb0140","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.1021\/acs.joc.8b01436","article-title":"Protecting-group-free Total synthesis and biological evaluation of 3-Methylkealiiquinone and structural analogues","volume":"83","author":"Ramadoss","year":"2018","journal-title":"J. Organomet. Chem."},{"issue":"54","key":"10.1016\/j.bioorg.2025.109245_bb0145","doi-asserted-by":"crossref","first-page":"30761","DOI":"10.1039\/C8RA06676K","article-title":"Total synthesis of kealiiquinone: the regio-controlled strategy for accessing its 1-methyl-4-arylbenzimidazolone core","volume":"8","author":"Ramadoss","year":"2018","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109245_bb0150","first-page":"41","article-title":"Solorio-Alvarado synthesis and biological evaluation of new 3,4-diarylmaleimides as enhancers (modulators) of doxorubicin cytotoxic activity on cultured tumor cells from a real case of breast Cancer","volume":"61","author":"Jessica","year":"2017","journal-title":"J. Mex. Chem. Soc."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109245_bb0155","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00044-019-02290-z","article-title":"Total synthesis of the linear and angular 3-methylated regioisomers of the marine natural product Kealiiquinone and biological evaluation of related Leucetta sp. alkaloids on human breast cancer","volume":"28","author":"Solorio-Alvarado","year":"2019","journal-title":"Med. Chem. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109245_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202300883","article-title":"Ningalins, pyrrole-bearing metabolites isolated from Didemnum spp. synthesis and MDR-reversion activity in Cancer therapy","volume":"21","author":"Segura-Quezada","year":"2024","journal-title":"Chem. Biodivers."},{"issue":"38","key":"10.1016\/j.bioorg.2025.109245_bb0165","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.2174\/0109298673292365240422104456","article-title":"Differential effect of 4H-benzo[d] [1,3]oxazines on the proliferation of breast Cancer cell lines","volume":"31","author":"Fraire-Soto","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109245_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202400640","article-title":"Multidrug resistance reversed by maleimide interactions. a biological and synthetic overview for an emerging field","author":"Hern\u00e1ndez-Vel\u00e1zquez","year":"2025","journal-title":"ChemBioChem"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109245_bb0175","article-title":"Synthesis and in\u00a0vivo evaluation of Fluorobenzyl metformin derivatives as potential drugs in the diabetes treatment","volume":"12","author":"Hern\u00e1ndez-Vel\u00e1zquez","year":"2023","journal-title":"As. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2025.109245_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129241","article-title":"Metformin, a biological and synthetic overview","volume":"86","author":"Hern\u00e1ndez-Vel\u00e1zquez","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109245_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202303803","article-title":"Synthesis and anti-inflammatory effect of simple 2,3-Diarylindoles. On route to new NSAID scaffolds","volume":"9","author":"Segura-Quezada","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.109245_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128649","article-title":"Novel 2-aryl-4-aryloxyquinoline-based fungistatics for Mucor circinelloides. Biological evaluation of activity, QSAR and docking study","volume":"63","author":"Nahide","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109245_bb0195","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy","volume":"14","author":"Parkinson","year":"2002","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.bioorg.2025.109245_bb0200","series-title":"Oeuvres completes, Delahsve","author":"Charcot","year":"1892"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109245_bb0205","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109245_bb0210","first-page":"503","article-title":"Occupational and environmental causes of parkinsonism","volume":"7","author":"Tanner","year":"1992","journal-title":"Occup. Med."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109245_bb0215","first-page":"504","article-title":"Parkinson\u2019s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis","volume":"40","author":"DeMaagd","year":"2015","journal-title":"P t"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109245_bb0220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bioorg.2025.109245_bb0225","series-title":"Human Neuroanatomy, by Malcolm B. Carpenter and Jerome Sutin, Williams & Wilkins, Baltimore","first-page":"272","volume":"10","author":"Ball","year":"1983"},{"key":"10.1016\/j.bioorg.2025.109245_bb0230","first-page":"Ii3-10","article-title":"Pathoanatomy of Parkinson's disease","volume":"247 Suppl 2","author":"Braak","year":"2000","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109245_bb0235","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109245_bb0240","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/cn200110q","article-title":"Muscarinic acetylcholine receptor subtypes as potential drug targets for the treatment of schizophrenia, drug abuse and parkinson's disease","volume":"3","author":"Dencker","year":"2012","journal-title":"ACS Chem. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.bioorg.2025.109245_bb0245","first-page":"S148","article-title":"Acetylcholine-dopamine balance hypothesis in the striatum: an update","volume":"10","author":"Aosaki","year":"2010","journal-title":"Geriatr Gerontol Int"},{"issue":"10 Suppl","key":"10.1016\/j.bioorg.2025.109245_bb0250","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S1471-1931(00)00025-2","article-title":"Dopamine receptors: from structure to behavior","volume":"23","author":"Sealfon","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bioorg.2025.109245_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.01003","article-title":"Dopamine receptor subtypes, physiology and pharmacology: new ligands and concepts in schizophrenia","volume":"11","author":"Martel","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109245_bb0260","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1113\/JP274475","article-title":"Detection of phasic dopamine by D1 and D2 striatal medium spiny neurons","volume":"595","author":"Yapo","year":"2017","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109245_bb0265","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41467-017-02606-w","article-title":"Gs- versus golf-dependent functional selectivity mediated by the dopamine D(1) receptor","volume":"9","author":"Yano","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109245_bb0270","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.biopsych.2009.08.011","article-title":"Uncoupling the D1-N-methyl-D-aspartate (NMDA) receptor complex promotes NMDA-dependent long-term potentiation and working memory","volume":"67","author":"Nai","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"23","key":"10.1016\/j.bioorg.2025.109245_bb0275","doi-asserted-by":"crossref","first-page":"10601","DOI":"10.1021\/acs.jmedchem.6b01208","article-title":"Discovery of G protein-biased D2 dopamine receptor partial agonists","volume":"59","author":"Chen","year":"2016","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109245_bb0280","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/mp.2016.200","article-title":"Endocytosis following dopamine D(2) receptor activation is critical for neuronal activity and dendritic spine formation via Rabex-5\/PDGFR\u03b2 signaling in striatopallidal medium spiny neurons","volume":"22","author":"Shioda","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.bioorg.2025.109245_bb0285","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1530-0277.1996.tb05936.x","article-title":"Decreases in dopamine receptors but not in dopamine transporters in alcoholics","volume":"20","author":"Volkow","year":"1996","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.bioorg.2025.109245_bb0290","series-title":"Chapter Eleven - The Structure and Function of the Dopamine Transporter and its Role in CNS Diseases","first-page":"339","author":"McHugh","year":"2015"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109245_bb0295","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1523\/JNEUROSCI.22-02-00389.2002","article-title":"Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines","volume":"22","author":"Mor\u00f3n","year":"2002","journal-title":"J. Neurosci."},{"issue":"7552","key":"10.1016\/j.bioorg.2025.109245_bb0300","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature14431","article-title":"Neurotransmitter and psychostimulant recognition by the dopamine transporter","volume":"521","author":"Wang","year":"2015","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.bioorg.2025.109245_bb0305","doi-asserted-by":"crossref","first-page":"10172","DOI":"10.1021\/acs.jmedchem.7b01454","article-title":"Structure-activity relationship studies on a series of 3\u03b1-[Bis(4-fluorophenyl)methoxy]tropanes and 3\u03b1-[Bis(4-fluorophenyl)methylamino]tropanes as novel atypical dopamine transporter (DAT) inhibitors for the treatment of cocaine use disorders","volume":"60","author":"Zou","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109245_bb0310","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.pharmtox.44.101802.121622","article-title":"Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications","volume":"44","author":"Wess","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"26","key":"10.1016\/j.bioorg.2025.109245_bb0315","doi-asserted-by":"crossref","first-page":"8124","DOI":"10.1073\/pnas.1508846112","article-title":"Muscarinic regulation of dopamine and glutamate transmission in the nucleus accumbens","volume":"112","author":"Shin","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109245_bb0320","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1124\/jpet.111.187856","article-title":"Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's disease","volume":"340","author":"Xiang","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bioorg.2025.109245_bb0325","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fncel.2013.00055","article-title":"Cholinergic connectivity: it's implications for psychiatric disorders","volume":"7","author":"Scarr","year":"2013","journal-title":"Front. Cell. Neurosci."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109245_bb0330","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109245_bb0335","doi-asserted-by":"crossref","first-page":"16005","DOI":"10.1038\/s41598-017-16228-1","article-title":"Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia","volume":"7","author":"Lerner","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109245_bb0340","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00702-013-1008-y","article-title":"Treatment of Parkinson\u2019s disease in the advanced stage","volume":"120","author":"Ossig","year":"2013","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"4 Suppl 4","key":"10.1016\/j.bioorg.2025.109245_bb0345","first-page":"S1","article-title":"Canadian guidelines on Parkinson's disease","volume":"39","author":"Grimes","year":"2012","journal-title":"Can. J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109245_bb0350","first-page":"195","article-title":"Analysis and update of the human solute carrier (SLC) gene superfamily","volume":"3","author":"He","year":"2009","journal-title":"Hum. Genet."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109245_bb0355","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.bcp.2008.01.018","article-title":"Dopaminergic signaling in dendritic spines","volume":"75","author":"Yao","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109245_bb0360","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-4159.2011.07335.x","article-title":"Dopamine release mediated by the dopamine transporter, facts and consequences","volume":"118","author":"Leviel","year":"2011","journal-title":"J. Neurochem."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109245_bb0365","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/hmg\/ddh180","article-title":"Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis","volume":"13","author":"Jiang","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109245_bb0370","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ceca.2015.06.013","article-title":"Amphetamine activates calcium channels through dopamine transporter-mediated depolarization","volume":"58","author":"Cameron","year":"2015","journal-title":"Cell Calcium"},{"issue":"12","key":"10.1016\/j.bioorg.2025.109245_bb0375","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson\u2019s disease: dopamine, vesicles and alpha-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bioorg.2025.109245_bb0380","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.brainresbull.2020.02.001","article-title":"Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson's disease (PD) \u2013 A road to discovery?","volume":"157","author":"Jayaramayya","year":"2020","journal-title":"Brain Res. Bull."},{"issue":"13","key":"10.1016\/j.bioorg.2025.109245_bb0385","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/S0028-3908(00)00140-4","article-title":"Lobeline inhibits nicotine-evoked [3H]dopamine overflow from rat striatal slices and nicotine-evoked 86Rb+ efflux from thalamic synaptosomes","volume":"39","author":"Miller","year":"2000","journal-title":"Neuropharmacol"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109245_bb0390","first-page":"211","article-title":"Characterization of the electrophysiological properties of triple reuptake inhibitors on monoaminergic neurons","volume":"14","author":"Guiard","year":"2011","journal-title":"IJNP"},{"issue":"12","key":"10.1016\/j.bioorg.2025.109245_bb0395","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1017\/S1461145714000996","article-title":"The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats","volume":"17","author":"Sommer","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109245_bb0400","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s10787-020-00705-7","article-title":"Neuroprotective and anti-inflammatory activity of DAT inhibitor R-phenylpiracetam in experimental models of inflammation in male mice","volume":"28","author":"Zvejniece","year":"2020","journal-title":"Inflammopharmacol"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109245_bb0405","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0022-510X(88)90065-2","article-title":"Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by piroheptine and trihexyphenidyl","volume":"83","author":"Saitoh","year":"1988","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109245_bb0410","first-page":"629","article-title":"Response of tardive and L-dopa-induced dyskinesias to antidepressants","volume":"14","author":"El-Awar","year":"1987","journal-title":"Can. J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109245_bb0415","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1756-0500-6-220","article-title":"Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence","volume":"6","author":"Simmler","year":"2013","journal-title":"BMC. Res. Notes"},{"key":"10.1016\/j.bioorg.2025.109245_bb0420","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1326-8-14","article-title":"Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits","volume":"8","author":"Carvalho","year":"2013","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109245_bb0425","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/syn.10038","article-title":"Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications","volume":"43","author":"Volkow","year":"2002","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109245_bb0430","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/npp.2012.204","article-title":"Powerful cocaine-like actions of 3,4-Methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018Bath salts\u2019 products","volume":"38","author":"Baumann","year":"2013","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.bioorg.2025.109245_bb0435","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neuropharm.2017.12.006","article-title":"Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats","volume":"131","author":"Tunstall","year":"2018","journal-title":"Neuropharmacol"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109245_bb0440","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41386-019-0366-z","article-title":"Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders","volume":"44","author":"Newman","year":"2019","journal-title":"Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109245_bb0445","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1021\/acsptsci.3c00322","article-title":"Series of (([1,1\u2032-biphenyl]-2-yl)methyl)sulfinylalkyl alicyclic amines as novel and high affinity atypical dopamine transporter inhibitors with reduced hERG activity","volume":"7","author":"Ku","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"8025","key":"10.1016\/j.bioorg.2025.109245_bb0450","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41586-024-07739-9","article-title":"Structure of the human dopamine transporter and mechanisms of inhibition","volume":"632","author":"Srivastava","year":"2024","journal-title":"Nature"},{"issue":"37","key":"10.1016\/j.bioorg.2025.109245_bb0455","doi-asserted-by":"crossref","first-page":"9564","DOI":"10.1039\/C5OB01463H","article-title":"Dicyanovinyl-substituted J147 analogue inhibits oligomerization and fibrillation of \u03b2-amyloid peptides and protects neuronal cells from \u03b2-amyloid-induced cytotoxicity","volume":"13","author":"Kim","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109245_bb0460","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1096\/fj.11-195016","article-title":"A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances l-DOPA benefit in parkinsonian primates","volume":"26","author":"Johnston","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.bioorg.2025.109245_bb0465","article-title":"Monoamine reuptake inhibitors in Parkinson's disease","volume":"2015","author":"Huot","year":"2015","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.bioorg.2025.109245_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00682","article-title":"The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent Tetrabenazine and increases progressive ratio responding","volume":"10","author":"Rotolo","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109245_bb0475","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/j.1471-4159.1985.tb08803.x","article-title":"Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin","volume":"44","author":"Hyttel","year":"1985","journal-title":"J. Neurochem."},{"issue":"236","key":"10.1016\/j.bioorg.2025.109245_bb0480","doi-asserted-by":"crossref","first-page":"236re4","DOI":"10.1126\/scitranslmed.3008169","article-title":"An antidepressant decreases CSF a\u03b2 production in healthy individuals and in transgenic AD mice","volume":"6","author":"Sheline","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioorg.2025.109245_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115593","article-title":"Discovery of bakuchiol as an AIM2 inflammasome activator and cause of hepatotoxicity","volume":"298","author":"Liu","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109245_bb0490","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.bcp.2008.01.014","article-title":"Bakuchiol analogs inhibit monoamine transporters and regulate monoaminergic functions","volume":"75","author":"Zhao","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109245_bb0495","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/jnc.16179","article-title":"Cryo-EM structure of the dopamine transporter with a novel atypical non-competitive inhibitor bound to the orthosteric site","volume":"168","author":"Pedersen","year":"2024","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bioorg.2025.109245_bb0500","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fncom.2013.00100","article-title":"The advantage of flexible neuronal tunings in neural network models for motor learning","volume":"7","author":"Marongelli","year":"2013","journal-title":"Front. Comput. Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109245_bb0505","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(01)00785-3","article-title":"Negative interaction of dopamine D2 receptor antagonists and GBR 12909 and GBR 12935 dopamine uptake inhibitors in the nucleus accumbens","volume":"414","author":"Rahman","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109245_bb0510","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bcp.2007.08.007","article-title":"Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction","volume":"75","author":"Rothman","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109245_bb0515","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuroscience.2011.03.017","article-title":"Low and high affinity dopamine transporter inhibitors block dopamine uptake within 5 sec of intravenous injection","volume":"182","author":"Yorgason","year":"2011","journal-title":"Neuroscience"},{"issue":"14","key":"10.1016\/j.bioorg.2025.109245_bb0520","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1021\/acs.jcim.3c00477","article-title":"Structure-based discovery of a novel allosteric inhibitor against human dopamine transporter","volume":"63","author":"Deng","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2025.109245_bb0525","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuroscience.2024.02.003","article-title":"Acute Administration of Lactate Exerts Antidepressant-like Effect through cAMP-dependent protein synthesis","volume":"542","author":"Zhang","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.bioorg.2025.109245_bb0530","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1286061","article-title":"Ansofaxine hydrochloride inhibits tumor growth and enhances anti-TNFR2 in murine colon cancer model","volume":"14","author":"Jing","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109245_bb0535","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejphar.2015.06.041","article-title":"Amitifadine, a triple monoamine re-uptake inhibitor, reduces nicotine self-administration in female rats","volume":"764","author":"Levin","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109245_bb0540","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/syn.21538","article-title":"Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder","volume":"66","author":"Bymaster","year":"2012","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109245_bb0545","first-page":"53","article-title":"Effects of levophacetoperane, pemoline, fenozolone, and centrophenoxine on catecholamines and serotonin uptake in various parts of the rat brain","volume":"187","author":"Ramirez","year":"1978","journal-title":"C R Acad Hebd Seances Acad Sci D"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109245_bb0550","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00213-013-3391-3","article-title":"Evaluation of safety and tolerability, pharmacokinetics, and pharmacodynamics of BMS-820836 in healthy subjects: a placebo-controlled, ascending single-dose study","volume":"231","author":"Risinger","year":"2014","journal-title":"Psychopharmacol"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109245_bb0555","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1021\/acs.jmedchem.4c00159","article-title":"Discovery and optimization of Tetrahydroisoquinoline derivatives to enhance lysosome biogenesis as preclinical candidates for the treatment of Alzheimer's disease","volume":"67","author":"Zhou","year":"2024","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2025.109245_bb0560","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/0024-3205(88)90131-2","article-title":"Pure uptake blockers of dopamine can reduce prolactin secretion: studies with diclofensine","volume":"42","author":"Di Renzo","year":"1988","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109245_bb0565","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/clpt.1986.100","article-title":"Effect of diclofensine, a novel antidepressant, on peripheral adrenergic function","volume":"39","author":"Gasi\u0107","year":"1986","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2025.109245_bb0570","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejphar.2018.10.028","article-title":"Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter","volume":"842","author":"Fraser-Spears","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109245_bb0575","first-page":"214","article-title":"Some remarks on the treatment of post-encephalitic oculogyric crises with BENZTROPINE METHANESULFONATE","volume":"1","author":"Paulson","year":"1965","journal-title":"Int. J. Neuropsychiatry"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109245_bb0580","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/JCP.0000000000000911","article-title":"Association of Antidepressant use with Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological study","volume":"38","author":"Guo","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109245_bb0585","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1021\/cr9700538","article-title":"Chemistry, design, and structure-activity relationship of cocaine antagonists","volume":"100","author":"Singh","year":"2000","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.109245_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.12.005","article-title":"Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter","volume":"147","author":"Reith","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109245_bb0595","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1073\/pnas.89.16.7782","article-title":"Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding","volume":"89","author":"Kitayama","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"20","key":"10.1016\/j.bioorg.2025.109245_bb0600","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1021\/jm00046a029","article-title":"Structure-activity relationship studies of N-sulfonyl analogs of cocaine: role of ionic interaction in cocaine binding","volume":"37","author":"Kozikowski","year":"1994","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109245_bb0605","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1124\/jpet.105.085829","article-title":"Recognition of Benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and Mazindol as a function of a DAT transmembrane 1 aspartic acid residue","volume":"314","author":"Ukairo","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109245_bb0610","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1021\/op000018u","article-title":"Salt selection and optimisation procedures for pharmaceutical new chemical entities","volume":"4","author":"Bastin","year":"2000","journal-title":"Org. Process. Res. Dev."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109245_bb0615","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3109\/00498259509061899","article-title":"Phase I and II metabolites of benztropine in rat urine and bile","volume":"25","author":"He","year":"1995","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109245_bb0620","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.18632\/oncotarget.13537","article-title":"New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109245_bb0625","first-page":"39","article-title":"Anticholinergic drugs used in Parkinson's disease: an overlooked class of drugs from a pharmacokinetic perspective","volume":"2","author":"Brocks","year":"1999","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109245_bb0630","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/00048678609161335","article-title":"A study of the need for anticholinergic medication in patients treated with long-term antipsychotics","volume":"20","author":"Caradoc-Davies","year":"1986","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109245_bb0635","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1756-0500-4-559","article-title":"A short update on the structure of drug binding sites on neurotransmitter transporters","volume":"4","author":"Gabrielsen","year":"2011","journal-title":"BMC. Res. Notes"},{"key":"10.1016\/j.bioorg.2025.109245_bb0640","first-page":"362","article-title":"\u03c3 receptor effects of N-substituted Benztropine analogs: implications for antagonism of cocaine self-administration","volume":"1):2-13","author":"Hiranita","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109245_bb0645","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2010.08.021","article-title":"The binding sites for benztropines and dopamine in the dopamine transporter overlap","volume":"60","author":"Bisgaard","year":"2011","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109245_bb0650","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1021\/op970101q","article-title":"Development of a manufacturing process for Zatosetron maleate","volume":"1","author":"Burks","year":"1997","journal-title":"Org. Process. Res. Dev."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109245_bb0655","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0040-4020(59)80012-0","article-title":"Stereochemistry of the reduction of tropinone","volume":"6","author":"Beckett","year":"1959","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2025.109245_bb0660","series-title":"Benzhydryl Ethers of Tropines and their Production","first-page":"1","author":"Richard","year":"1952"},{"issue":"36","key":"10.1016\/j.bioorg.2025.109245_bb0665","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1016\/S0040-4039(00)95578-3","article-title":"Stereocontrolled synthesis of tropanol derivatives via palladium -catalyzed reactions","volume":"28","author":"B\u00e4ckvall","year":"1987","journal-title":"Tetrahedron Lett."},{"issue":"18","key":"10.1016\/j.bioorg.2025.109245_bb0670","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1021\/jm980701v","article-title":"CoMFA study of novel phenyl ring-substituted 3alpha-(diphenylmethoxy)tropane analogues at the dopamine transporter","volume":"42","author":"Newman","year":"1999","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2025.109245_bb0675","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1021\/jm00020a006","article-title":"Novel 4\u2032-substituted and 4\u2032,4\u2033-disubstituted 3 alpha-(diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors","volume":"38","author":"Newman","year":"1995","journal-title":"J. Med. Chem."},{"issue":"26","key":"10.1016\/j.bioorg.2025.109245_bb0680","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1021\/jm970525a","article-title":"Novel N-substituted 3\u03b1-[Bis(4\u2032-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter","volume":"40","author":"Agoston","year":"1997","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109245_bb0685","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0960-894X(02)00155-5","article-title":"Enantioselective synthesis of S-(+)-2\u03b2-carboalkoxy-3\u03b1-[bis(4-fluorophenyl)methoxy]tropanes as novel probes for the dopamine transporter","volume":"12","author":"Zou","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"21","key":"10.1016\/j.bioorg.2025.109245_bb0690","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1021\/jm060762q","article-title":"Structure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation","volume":"49","author":"Zou","year":"2006","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2025.109245_bb0695","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1021\/jm0300375","article-title":"Structure-activity relationship comparison of (S)-2beta-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes and (R)-2beta-substituted 3beta-(3,4-dichlorophenyl)tropanes at the dopamine transporter","volume":"46","author":"Zou","year":"2003","journal-title":"J. Med. Chem."},{"issue":"28","key":"10.1016\/j.bioorg.2025.109245_bb0700","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1016\/S0040-4020(02)00530-6","article-title":"A modified palladium catalysed reductive amination procedure","volume":"58","author":"Berdini","year":"2002","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2025.109245_bb0705","series-title":"Enantioselective Synthesis of AMINOTROPANE Compound","author":"Conza","year":"2022"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109245_bb0710","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00044-018-2203-z","article-title":"Synthesis and biological investigations of 3\u03b2-aminotropane arylamide derivatives with atypical antipsychotic profile","volume":"27","author":"Stefanowicz","year":"2018","journal-title":"Med. Chem. Res."},{"issue":"6361","key":"10.1016\/j.bioorg.2025.109245_bb0715","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1126\/science.aan6245","article-title":"MOF-derived cobalt nanoparticles catalyze a general synthesis of amines","volume":"358","author":"Jagadeesh","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.109245_bb0720","series-title":"BENZOXAZOLE CARBOXAMIDES for treating CINV and IBS-d","author":"Fairfax","year":"2006"},{"issue":"24","key":"10.1016\/j.bioorg.2025.109245_bb0725","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1016\/j.bmcl.2005.08.111","article-title":"N-8-substituted benztropinamine analogs as selective dopamine transporter ligands","volume":"15","author":"Grundt","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109245_bb0730","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1021\/jm030453p","article-title":"Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3\u03b2-(substituted phenyl)-2\u03b2-(3\u2032-substituted isoxazol-5-yl)tropanes","volume":"47","author":"Carroll","year":"2004","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2025.109245_bb0735","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1039\/B405768F","article-title":"Combinatorial synthesis of benztropine libraries and their evaluation as monoamine transporter inhibitors","volume":"2","author":"Pedersen","year":"2004","journal-title":"Org. Biomol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2025.109245_bb0740","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brainres.2005.07.012","article-title":"Cocaine self-administration and locomotor activity are altered in Lewis and F344 inbred rats by RTI 336, a 3-phenyltropane analog that binds to the dopamine transporter","volume":"1055","author":"Haile","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.bioorg.2025.109245_bb0745","series-title":"chromen-2-one derivatives and their use as monoamine neuro-transmitter re-uptake inhibitors","author":"Peters","year":"2011"},{"issue":"15","key":"10.1016\/j.bioorg.2025.109245_bb0750","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1111\/bph.16362","article-title":"A novel reuptake inhibitor, IP2015, induces erection by increasing central dopamine and peripheral nitric oxide release","volume":"181","author":"Comerma-Steffensen","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109245_bb0755","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.euroneuro.2013.10.007","article-title":"Tesofensine, a novel triple monoamine re-uptake inhibitor with anti-obesity effects: dopamine transporter occupancy as measured by PET","volume":"24","author":"Appel","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bioorg.2025.109245_bb0760","series-title":"Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors","author":"Gouliaev","year":"2002"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T09:46:38Z","timestamp":1767692798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825011253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":152,"alternative-id":["S0045206825011253"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109245","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of benztropine-based DAT blockers for Parkinson's disease interventions: A biologic and synthetic overview","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109245"}}